Ibrance / Reampla (palbociclib) 125 mg, 21 capsules, Pfizer Ibrance (palbociclib) is used for HR-positive, HER2-negative locally advanced or metastatic breast cancer. International medicine delivery within 4-5 days. Payment on delivery. Contact +380996042415.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
-
indications
- Ibrance is indicated for the treatment of hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
- letrozole as initial hormonal therapy in postmenopausal women;
- Fulvestrant in women with disease progression after endocrine therapy.
- Indications for use in combination with letrozole was approved in accordance with the accelerated approval procedure based on progression-free survival. Full approval for this indication is subject to verification and description of clinical benefit in a confirmatory trial.
- Trade name:Ibrance / Reampla
- Chemical name:Palbociclib
- Dosage:125 mg
- Quantity:21
- Dosage form:Tablets
- Manufacturer:Pfizer
No reviews yet
